Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.

IF 1.8 4区医学 Q3 GENETICS & HEREDITY Familial Cancer Pub Date : 2023-10-01 Epub Date: 2023-06-21 DOI:10.1007/s10689-023-00341-4

Rachel Hodan, Linda Rodgers-Fouche, Anu Chittenden, Mev Dominguez-Valentin, James Ferriss, Lauren Gima, Ole-Petter R Hamnvik, Gregory E Idos, Kevin Kline, Diane R Koeller, Jessica M Long, Danielle McKenna, Charles Muller, Maxton Thoman, Anton Wintner, Bronwyn S Bedrick

{"title":"Cancer surveillance for transgender and gender diverse patients with Lynch syndrome: a practice resource of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer.","authors":"Rachel Hodan, Linda Rodgers-Fouche, Anu Chittenden, Mev Dominguez-Valentin, James Ferriss, Lauren Gima, Ole-Petter R Hamnvik, Gregory E Idos, Kevin Kline, Diane R Koeller, Jessica M Long, Danielle McKenna, Charles Muller, Maxton Thoman, Anton Wintner, Bronwyn S Bedrick","doi":"10.1007/s10689-023-00341-4","DOIUrl":null,"url":null,"abstract":"<p><p>Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate cancer surveillance and risk-reducing procedures. There is a lack of care provider knowledge about TGD health management. Lynch syndrome (LS) is one of the most common hereditary cancer syndromes, affecting an estimated 1 in 279 individuals. There are no clinical guidelines specific for TGD individuals with LS, highlighting a need to improve the quality of care for this population. There is an urgent need for cancer surveillance recommendations for TGD patients. This commentary provides recommendations for cancer surveillance, risk-reducing strategies, and genetic counseling considerations for TGD patients with LS.</p>","PeriodicalId":12336,"journal":{"name":"Familial Cancer","volume":" ","pages":"437-448"},"PeriodicalIF":1.8000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Familial Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10689-023-00341-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/21 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}

引用次数: 0

Abstract

Transgender and gender diverse (TGD) populations with hereditary cancer syndromes face unique obstacles to identifying and obtaining appropriate cancer surveillance and risk-reducing procedures. There is a lack of care provider knowledge about TGD health management. Lynch syndrome (LS) is one of the most common hereditary cancer syndromes, affecting an estimated 1 in 279 individuals. There are no clinical guidelines specific for TGD individuals with LS, highlighting a need to improve the quality of care for this population. There is an urgent need for cancer surveillance recommendations for TGD patients. This commentary provides recommendations for cancer surveillance, risk-reducing strategies, and genetic counseling considerations for TGD patients with LS.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

癌症对林奇综合征跨性别和不同性别患者的监测：美洲癌症遗传性胃肠道癌症合作小组的实践资源。

患有遗传性癌症综合征的跨性别和性别多样化（TGD）人群在识别和获得适当的癌症监测和风险降低程序方面面临着独特的障碍。护理提供者缺乏关于TGD健康管理的知识。林奇综合征（LS）是最常见的遗传性癌症综合征之一，估计每279人中就有1人受到影响。没有专门针对患有LS的TGD患者的临床指南，强调需要提高这一人群的护理质量。目前急需为TGD患者提供癌症监测建议。这篇评论为患有LS的TGD患者的癌症监测、风险降低策略和基因咨询提供了建议。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Familial Cancer 医学-遗传学

CiteScore

4.10

自引率

4.50%

发文量

审稿时长

6-12 weeks

期刊介绍： In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers. Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician. The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.